Prevalence of Bacterial and Mycobacterial Spondylodiscitis Coinfection
Bacterial and mycobacterial coinfection in spondylodiscitis is exceedingly rare, with only isolated case reports documented in the literature, and no established prevalence data exists.
Evidence Base
The available evidence consists entirely of individual case reports rather than systematic prevalence studies:
Single documented case (2006): A 54-year-old man with tuberculous spondylodiscitis and concurrent E. coli infection from cholecystitis, treated successfully with combined antitubercular quadritherapy and specific antibiotics 1. The authors explicitly noted this was the first reported case of mycobacterial-bacterial coinfection in spondylodiscitis.
Melioidosis-tuberculosis coinfection (2023): One case report of concurrent Burkholderia pseudomallei and Mycobacterium tuberculosis in lumbar spondylodiscitis, described as "rare" with no prior reports of this specific combination 2.
Clinical Context
Why Coinfection is Uncommon
The pathophysiology and clinical presentations differ substantially between bacterial and mycobacterial spondylodiscitis:
- Bacterial (pyogenic) infections typically present acutely with intense inflammatory response, brisk neutrophilic inflammation, and elevated acute-phase reactants 3
- Mycobacterial (tuberculous) infections present subacutely with longer symptom duration, constitutional symptoms, and less intense acute-phase response 3
These divergent patterns make simultaneous infection biologically and clinically unusual.
Diagnostic Implications
Major international guidelines 4, 5 extensively discuss differentiating between bacterial and mycobacterial causes but do not address coinfection scenarios, reflecting the rarity of this presentation. The 2015 IDSA guidelines emphasize obtaining both bacterial and mycobacterial cultures from biopsy specimens 4, which would theoretically detect coinfection if present, yet provide no prevalence estimates.
Practical Considerations
When evaluating spondylodiscitis:
- Assume single pathogen unless clinical course is atypical or treatment response is inadequate
- Send comprehensive cultures (bacterial, mycobacterial, fungal) on all biopsy specimens as standard practice 4
- Consider coinfection only when:
- Mixed imaging features (e.g., disc involvement typical of bacterial infection plus anterior longitudinal ligament spread typical of TB)
- Partial response to single-pathogen therapy
- Epidemiological risk factors for both (e.g., healthcare exposure plus TB endemic area)
The absence of prevalence data in contemporary reviews 6, 7, 8, 3 and major guidelines 4, 5 confirms this is not a recognized clinical pattern requiring routine consideration.